Note: Ingredients listed on restricted chemical lists
EC/CAS
203-234-3/104-76-7
Name of the chemical
2-ethyl-1-hexanol
Concentration
≥70
EC/CAS
202-049-5/91-20-3
Name of the chemical
Naphthalene,3
Concentration
<1
EC/CAS
203-868-0/111-42-2
Name of the chemical
N,N-Diethanolamine (Ethanol, 2,2'-iminobis-)
Concentration
<1
General Information
Version
1.1
Revision date
2023-11-13
Product name
PETROL INJECTOR CLEANER
Manufacturer Name
Millers Oils Ltd
Emergency telephone
+44 (0)1484 713201, 0845 4647
Icons in SDS
Company Information
company name
Millers Oils Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
h.s@millersoils.co.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H412
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May be fatal if swallowed and enters airways. Harmful to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS08
Signal word
Danger
Contains
HYDROCARBONS, C11-14, N-ALKANES, ISOALKANES, CYCLIC, <2% AROMATICS; HYDROCARBONS, C10, AROMATICS, <1% NAPHTHALENE
Hazard statements
H304 - May be fatal if swallowed and enters airways. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P331 - Do NOT induce vomiting. P405 - Store locked up. P102 - Keep out of reach of children. P273 - Avoid release to the environment. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
